4//SEC Filing
Lemercier Jean-Luc M 4
Accession 0001225208-24-005888
CIK 0001099800other
Filed
May 8, 8:00 PM ET
Accepted
May 9, 7:39 PM ET
Size
11.3 KB
Accession
0001225208-24-005888
Insider Transaction Report
Form 4
Lemercier Jean-Luc M
CVP, EMEA, Canada, Latin Amer
Transactions
- Award
Common Stock
2024-05-07+7,125→ 184,834.806 total - Tax Payment
Common Stock
2024-05-07$85.09/sh−46$3,914→ 184,788.806 total - Award
Performance Rights
2024-05-07+7,125→ 7,125 totalFrom: 2027-05-07→ Common Stock (7,125 underlying) - Award
Employee Stock Option (Right to Acquire)
2024-05-07+42,200→ 42,200 totalExercise: $85.84From: 2025-05-07Exp: 2031-05-06→ Common Stock (42,200 underlying)
Footnotes (3)
- [F1]These restricted stock units were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
- [F2]These options were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments.
- [F3]Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2027. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeother
Related Parties
1- filerCIK 0001710625
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 7:39 PM ET
- Size
- 11.3 KB